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Necrotizing scleritis is an uncommon but potential disastrous infection to the eye. It is
commonly caused by vaso-occlusive autoimmune diseases such as rheumatoid arthritis
or surgically-induced, and rarely due to infections. In this article, we presented a rare
case of necrotizing scleritis caused by herpes infection in an immunocompromised
patient. A 49 years old, retroviral positive gentleman presented to our clinic with a
painful, red right eye associated with watering, photophobia and blurring of vision.
His right eye rapidly deteriorated leading to an impending perforation of the sclera
despite intensive antimicrobial therapy. The patient was started on acyclovir ointment
and subsequently improved remarkably salvaging the eye from the need of an evis-
ceration. Although the visual prognosis was poor, structural integrity of the eye was
achieved.1. Introduction
Necrotizing scleritis is presumably the most severe and
destructive form of scleritis. The pathophysiological mechanism
is regarded as an immune complex reaction (type III hypersen-
sitivity reaction)[1]. Most of the time, scleritis is not caused by an
infectious agent[2] but rather trauma or surgically-induced. Here
we discussed a case of necrotizing scleritis, seen in a HIV
positive patient, which proved to be a challenge in management.
2. Case report
A 49 years old, HIV positive gentleman, on highly active
antiretroviral therapy, presented to our clinic with a painful, red
right eye. It was associated with watering, photophobia and
blurring of vision for the past 3 days. The condition was in
sudden onset and rapidly progressive. There were no similar
episodes previously and history of fever, recent trauma orsurgery to the eye. No features of systemic autoimmune diseases
such as joint pain, orogenital/skin ulcerations, rashes or photo-
sensitivity to sunlight were presented. A systemic review of
systems was grossly unremarkable. His visit to our clinic
revealed a visual acuity of 6/36 in the right eye and 6/7.5 in the
left eye. Intraocular pressures were 16 mmHg in both eyes. On
slit lamp examination of the affected eye, there was conjunctival
injection and corneal ulceration extending to the sclera on the
nasal side (Figure 1). The anterior chamber showed 3+ cells with
a hypopyon. Pupils were round and reactive. A fundus exami-
nation did not reveal any pathology. Examination of the fellow
eye was unremarkable.
A baseline investigation of full blood count and screening for
infections was normal. Autoimmune screening tests, tubercu-
losis workup and toxoplasma serology came back negative.
Corneal scrapping from the ulcer base grew Pseudomonas aer-
uginosa. Thus, the patient was started on a regime of topical
fortiﬁed gentamicin 0.9% eyedrops hourly, moxiﬂoxacin
eyedrops on an hourly basis, homatropine 2% eyedrops three
times daily, oral doxycycline 100 mg/day and oral vitamin C
1 g/day. However despite this treatment, the ulceration rapidly
progressed and the patient was soon found to develop a necro-
tizing scleritis adjacent to the corneal ulcer (Figure 2). To our
dismay, the nasal sclera thinned out with underlying uveal tissue
starting to bulge anteriorly with impending perforation
(Figures 3 and 4). Upon further examination we noticed a-NC-ND license (http://
Figure 1. Corneal ulceration beginning to develop on the nasal side.
Figure 2. Necrotizing scleritis adjacent to the corneal ulcer.
Figure 3. Progressive corneal and scleral thinning nasal side.
Figure 4. Impending perforation.
Figure 5. Rapid clinical improvement after starting ointment acyclovir
treatment.
Figure 6. Post treatment resolution with residual scarring.
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acyclovir to our previous treatment regimen. Soon after, a rapid
clinical improvement was noted (Figure 5). Areas of scleral
thinning and corneal ulceration started to resolve with ﬁbrosis
and conjunctivalization of the thinned out sclera. Subsequently,
his clinical course was otherwise uncomplicated and a steady
resolution of the ulcer also occurred (Figure 6). His ﬁnal visual
outcome was 6/60 with preservation of the ocular structural
integrity.3. Discussion
Scleritis is an inﬂammatory disease of the episcleral and the
deeper scleral tissues. The pain of episcleritis is less severe than
in scleritis[3]. It may be classiﬁed anatomically into anterior- and
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scleritis can be further subdivided into nodular, diffuse and
necrotizing. This condition typically presents with intense pain,
thinned out white avascular areas surrounded by inﬂammation of
the sclera and conjunctiva. Fundus examination may reveal
choroidal folds, subretinal mass, disc edema, macular edema,
annular ciliochoroidal detachment and serous retinal detach-
ment[1]. Autoimmune causes are far more common, of which
rheumatoid arthritis is by far the most common systemic
condition associated with scleritis. The other associated
diseases are Wegener's granulomatosis, systemic lupus
erythematosus, juvenile rheumatoid arthritis, polyarthritis
nodosa, relapsing polychondritis, psoriasis, gout, atopy, and
rosacea. The common infective causes reported are
tuberculosis, syphilis, herpes zoster and herpes simplex
virus[1]. In our case, autoimmune screenings and infective
screens came back negative except for the retroviral disease.
Herpes infection was clinically suspected, however we were
not able to isolate the virus.
Herpes zoster, which is a member of herpes virus family, is the
causative agent of chickenpox and zona zoster diseases[4]. Zona
zoster is the reactivation of the latent virus long after the
primary infection has resolved[4]. This condition is characterized
by eyelid necrosis, iritis, necrotizing keratitis, neurotrophic
keratitis with corneal melting, extraocular muscle paralysis,
internal ophthalmoplegia, cataract, chorioretinitis and optic
neuritis[5]. The pathophysiology of herpes zoster ophthalmicus
remains obscure[6]. Scleral weakening, seen in necrotizing
scleritis was commonly attributed to immune complex-mediated
vasculitis. However, there are reports of direct scleral invasion
by herpes zoster virus[6,7]. Our case was likely a reactivation of the
virus due to immunocompromised status of the individual, a fact
which the patient did not disclose to us. The condition was only
found out after the positive HIV results, following which he
admitted to his status and highly active antiretroviral therapy
treatment. A delay in diagnosis could possibly have led to
perforation and disastrous consequences.
A trial of acyclovir has been supported in cases where biopsy
is not possible and suspicion of herpetic infection is strong (i.e.,
unilateral disease and not responsive to steroids), 800 mg 3 times
daily orally or if there are unequivocal signs of herpes zoster
infection (e.g., herpes zoster ophthalmicus). It is acceptable to
use acyclovir 800 mg 5 times a day or famciclovir instead[8]. Theresponse to acyclovir would depend on whether there is an
autoimmune component[8]. Amongst the ﬁndings that aroused
suspicion in our case were its acute onset, failure to improve
despite existing antimicrobial treatment, unilateral presentation
and associated keratouveitis. Prompt administration of
acyclovir based on clinical suspicion was proved vital in the
prevention of scleral perforation. Steroids were not used in
this case as they may delay epithelial healing[7,8].
In conclusion, necrotizing scleritis is a disastrous and difﬁcult
condition to manage, especially in immunodeﬁcient subjects. In
cases where no response is seen to antimicrobial agents, a trial of
anti-viral agents may be proved beneﬁcial.
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